Thu, Nov 12, 2026 - Page 28
13819 indexed SquawkNews stories from this UTC day. Showing 3241-3360.
L
SMITH MICRO SOFTWARE Q3 REVENUE USD 5.017 MILLION
SMITH MICRO SOFTWARE Q3 REVENUE USD 5.017 MILLION
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
Erasca Reports Third Quarter 2026 Business Updates and Financial Results
ERAS-0015 granted FDA Fast Track Designation for metastatic pancreatic adenocarcinoma; advancing tow
REGULATION | Nov 12, 2026, 09:01 PM UTC
L
Arrowhead Pharmaceuticals (ARWR) Reports FY2026 Results; Financial Figures Not Provided
Arrowhead Pharmaceuticals announced financial results for its fiscal year ended September 30, 2026. The supplied release does not include the results figures.Material DetailsContext by AI AnalystThis is the company’s ann
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
HeartBeam Reports Third Quarter 2026 Results
Redirected the Majority of Company Resources to Heart Attack Assessment, a Market Opportunity 4x Lar
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
MACROGENICS Q3 REVENUE USD 18.7 MILLION VS. IBES ESTIMATE USD 46.4 MILLION
MACROGENICS Q3 REVENUE USD 18.7 MILLION VS. IBES ESTIMATE USD 46.4 MILLION
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
TALPHERA, INC Q3 NET INCOME FROM CONT OPS USD -4.018 MILLION
TALPHERA, INC Q3 NET INCOME FROM CONT OPS USD -4.018 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
M
Applied Materials Announces Fiscal 2026 Results
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
SMITH MICRO SOFTWARE Q3 GROSS PROFIT USD 4.096 MILLION
SMITH MICRO SOFTWARE Q3 GROSS PROFIT USD 4.096 MILLION
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
HawkEye 360 Announces Third Quarter 2026 Financial Results
Revenue of $59.3 million, up 84% compared to the prior-year period of $32.2 million Achieved record
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
SMITH MICRO SOFTWARE Q3 NET INCOME USD -1.698 MILLION
SMITH MICRO SOFTWARE Q3 NET INCOME USD -1.698 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
Erasca Reports Third Quarter 2026 Business Updates and Financial Results
Erasca Reports Third Quarter 2026 Business Updates and Financial Results ERAS-0015 granted FDA Fast
REGULATION | Nov 12, 2026, 09:01 PM UTC
L
Applied Materials Reports 4Q Gross Margin of 50.4%
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
HEARTFLOW INC Q3 REVENUE USD 72.857 MILLION
HEARTFLOW INC Q3 REVENUE USD 72.857 MILLION
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
TALPHERA, INC Q3 NET INCOME USD -4.018 MILLION
TALPHERA, INC Q3 NET INCOME USD -4.018 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
IZEA WORLDWIDE Q3 NET INCOME USD -400 THOUSAND
IZEA WORLDWIDE Q3 NET INCOME USD -400 THOUSAND
FX | Nov 12, 2026, 09:01 PM UTC
L
HEARTBEAM Q3 BASIC EPS USD -0.05
HEARTBEAM Q3 BASIC EPS USD -0.05
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
IZEA WORLDWIDE Q3 ADJUSTED EBITDA USD -200 THOUSAND
IZEA WORLDWIDE Q3 ADJUSTED EBITDA USD -200 THOUSAND
FX | Nov 12, 2026, 09:01 PM UTC
L
SMITH MICRO REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
SMITH MICRO REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
TALPHERA, INC Q3 INCOME FROM OPERATIONS USD -4.136 MILLION
TALPHERA, INC Q3 INCOME FROM OPERATIONS USD -4.136 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
BLOSSOMHILL THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
BLOSSOMHILL THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2026 Financial Results and Provide Corporate Update
WILMINGTON, Del., Nov. 12, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc.
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
HEARTFLOW INC Q3 INCOME FROM OPERATIONS USD -13.846 MILLION
HEARTFLOW INC Q3 INCOME FROM OPERATIONS USD -13.846 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results
Conference Call and Webcast Today, November 12, 2026, at 4:30 p.m. ET PASADENA, Calif.--(BUSINESS
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Smith Micro Reports Third Quarter 2026 Financial Results
Smith Micro Software, Inc. (NASDAQ:SMSI) (“Smith Micro” or the “Company”) today reported financial results for its third quarter ended September 30, 2026.“Our third quarter marked our third consecutive quarter of sequent
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
HEARTBEAM Q3 NET INCOME USD -3.01 MILLION
HEARTBEAM Q3 NET INCOME USD -3.01 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
HEARTBEAM Q3 INCOME FROM OPERATIONS USD -3.457 MILLION
HEARTBEAM Q3 INCOME FROM OPERATIONS USD -3.457 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
Lifeway Foods® Reports Record High Quarterly Net Sales, Extends Kefir Category Leadership in Third Quarter 2026
28th consecutive quarter of year-over-year net sales growth; year-to-date 2026 net sales up 25.8% MO
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced financial results for its 2026 fiscal year ended September 30, 2026. The Company is hosting a conference call today, November 12, 2026, at 4:30 p.m. ET to dis
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
HeartBeam Reports Third Quarter 2026 Results
HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today reported its financial and operational results for the third quarter end
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Kodiak Sciences Inc. (KOD) Reports $66.2M Q3 Net Loss and Raises $69M
Kodiak reported a Q3 2026 net loss of $66.2M ($1.05 per share), versus $61.5M ($1.16 per share) in Q3 2025. It raised $69M in net proceeds through ATM stock sales after quarter-end and expects its $88.7M cash balance to
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
PRIME MEDICINE, INC. Q3 EPS USD -0.22
PRIME MEDICINE, INC. Q3 EPS USD -0.22
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
BRIEF-Rocket Pharmaceuticals Q3 EPS USD -0.43
BRIEF-Rocket Pharmaceuticals Q3 EPS USD -0.43 Nov 12 (Reuters) - Rocket Pharmaceuticals Q3 net incom
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
Smith Micro 3Q Rev $5.02M >SMSI
Smith Micro 3Q Rev $5.02M >SMSI
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
HAWKEYE 360 ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
HAWKEYE 360 ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
NRX PHARMACEUTICALS, INC. (NASDAQ:NRXP) TO REPORT THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE
NRX PHARMACEUTICALS, INC. (NASDAQ:NRXP) TO REPORT THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDE C
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
PRIME MEDICINE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
PRIME MEDICINE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
LIFEWAY FOODS Q3 SALES USD 67.797 MILLION
LIFEWAY FOODS Q3 SALES USD 67.797 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
Smith Micro 3Q Loss/Shr 30c >SMSI
Smith Micro 3Q Loss/Shr 30c >SMSI
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
HEARTBEAM REPORTS THIRD QUARTER 2026 RESULTS
HEARTBEAM REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Smith Micro 3Q Loss $1.7M >SMSI
Smith Micro 3Q Loss $1.7M >SMSI
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Ascend Wellness Holdings (AAWH.U) Q3 Revenue Rises 4.2% to $130.0M
Q3 2026 revenue was $130.0M, up 4.2% year over year and 3.1% sequentially. Net loss was $28.0M; Q2 net loss was $9.8M, including a one-time $14.8M tax-reserve release.Material DetailsContext by AI AnalystThis is a quarte
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
MacroGenics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate Progress
MacroGenics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate Progress Co
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Total revenues were $19.0 million for the third quarter of 2026 Emrosi® revenues of $9.0 million inc
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
PRIME MEDICINE, INC. Q3 NET INCOME USD -39.043 MILLION
PRIME MEDICINE, INC. Q3 NET INCOME USD -39.043 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
BRIEF-Ascend Wellness Q3 EPS USD -0.14
BRIEF-Ascend Wellness Q3 EPS USD -0.14 Nov 12 (Reuters) - Ascend Wellness Q3 pretax profit USD -17.4
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
ARROWHEAD PHARMACEUTICALS REPORTS 2026 FISCAL YEAR-END RESULTS
ARROWHEAD PHARMACEUTICALS REPORTS 2026 FISCAL YEAR-END RESULTS
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
BRIEF-Ascend Wellness Q3 EPS USD -0.14
Nov 12 (Reuters) - Ascend Wellness Q3 pretax profit USD -17.418 million.
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
Heartbeam 3Q Loss $3.01M >BEAT
Heartbeam 3Q Loss $3.01M >BEAT
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
POSaBIT Reports Third Quarter 2026 Financial Results
POSaBIT Systems Corporation (CSE:PBIT, OTC:POSAF) (the “Company” or “POSaBIT”), a leading provider of Point of Sale and payment solutions for the cannabis industry, today announced its financial results for the third qua
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
BRIEF-Kodiak Sciences Q3 Net Income USD -66.223 Million
Nov 12 (Reuters) - Kodiak Sciences Q3 basic EPS USD -1.05.
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
IZEA WORLDWIDE Q3 REVENUE USD 6.2 MILLION
IZEA WORLDWIDE Q3 REVENUE USD 6.2 MILLION
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
Curis 3Q Loss/Shr $1.94 >CRIS
Curis 3Q Loss/Shr $1.94 >CRIS
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Curis 3Q Loss $8.12M >CRIS
Curis 3Q Loss $8.12M >CRIS
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
NUCANA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
NUCANA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Heartbeam 3Q Loss/Shr 5c >BEAT
Heartbeam 3Q Loss/Shr 5c >BEAT
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
LIFEWAY FOODS Q3 INCOME FROM OPERATIONS USD 1.085 MILLION
LIFEWAY FOODS Q3 INCOME FROM OPERATIONS USD 1.085 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
IZEA REPORTS Q3 2026 REVENUE OF $6.2 MILLION, 94% INCREASE IN MANAGED SERVICES BOOKINGS
IZEA REPORTS Q3 2026 REVENUE OF $6.2 MILLION, 94% INCREASE IN MANAGED SERVICES BOOKINGS
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
PRIME MEDICINE, INC. Q3 INCOME FROM OPERATIONS USD -39.926 MILLION
PRIME MEDICINE, INC. Q3 INCOME FROM OPERATIONS USD -39.926 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
POSaBIT Reports Third Quarter 2026 Financial Results
Point of Sale Revenue Up 39% Year Over Year in Q3 Gross Profit Up 6% Year Over Year in Q3 TORONTO &
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
BlossomHill Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
BlossomHill Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
BRIEF-Rocket Pharmaceuticals Q3 EPS USD -0.43
Nov 12 (Reuters) - Rocket Pharmaceuticals Q3 net income USD -49.2 million.
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
Micron Announces Participation in Investor Events
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update
NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update Development Program
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Lifeway Foods 3Q EPS 2c >LWAY
Lifeway Foods 3Q EPS 2c >LWAY
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
Rocket Pharmaceuticals 3Q Loss $49.2M >RCKT
Rocket Pharmaceuticals 3Q Loss $49.2M >RCKT
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
HawkEye 360 3Q Loss $163,000 >HAWK
HawkEye 360 3Q Loss $163,000 >HAWK
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
LIFEWAY FOODS® REPORTS RECORD HIGH QUARTERLY NET SALES, EXTENDS KEFIR CATEGORY LEADERSHIP IN THIRD QUARTER 2026
LIFEWAY FOODS® REPORTS RECORD HIGH QUARTERLY NET SALES, EXTENDS KEFIR CATEGORY LEADERSHIP IN THIRD Q
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
HawkEye 360 3Q EPS 0c >HAWK
HawkEye 360 3Q EPS 0c >HAWK
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
Prime Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates
Prime Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates -- First p
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update
NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update Development Program
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
HawkEye 360 3Q Rev $59.3M >HAWK
HawkEye 360 3Q Rev $59.3M >HAWK
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights
Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights Ip
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
BRIEF-Kodiak Sciences Q3 Net Income USD -66.223 Million
BRIEF-Kodiak Sciences Q3 Net Income USD -66.223 Million Nov 12 (Reuters) - Kodiak Sciences Q3 basic
FX | Nov 12, 2026, 09:01 PM UTC
L
IZEA Reports Q3 2026 Revenue of $6.2 million, 94% increase in Managed Services Bookings
IZEA Reports Q3 2026 Revenue of $6.2 million, 94% increase in Managed Services Bookings ORLANDO, Fla
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2026 Financial Results and Provide Corporate Update
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2026 Financial Results and Provide C
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
CV SCIENCES Q3 OPERATING INCOME USD 377 THOUSAND
CV SCIENCES Q3 OPERATING INCOME USD 377 THOUSAND
FX | Nov 12, 2026, 09:01 PM UTC
M
Microsoft Restores Some Affected Servers Using Alternative Health Check
Microsoft validated an alternative service health check method, allowing a subset of affected servers to return to service.
EQUITY | Nov 12, 2026, 09:01 PM UTC
L
CV SCIENCES Q3 NET INCOME USD -93 THOUSAND
CV SCIENCES Q3 NET INCOME USD -93 THOUSAND
FX | Nov 12, 2026, 09:01 PM UTC
L
CV SCIENCES Q3 GROSS PROFIT USD 1.514 MILLION
CV SCIENCES Q3 GROSS PROFIT USD 1.514 MILLION
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
CV SCIENCES Q3 PRETAX PROFIT USD -93 THOUSAND
CV SCIENCES Q3 PRETAX PROFIT USD -93 THOUSAND
EARNINGS | Nov 12, 2026, 09:01 PM UTC
L
FRMO CORP. Q1 OPERATING INCOME BEFORE TAX USD -139.54 MILLION
FRMO CORP. Q1 OPERATING INCOME BEFORE TAX USD -139.54 MILLION
FX | Nov 12, 2026, 09:01 PM UTC
L
FRMO CORP. Q1 REVENUE USD 802 THOUSAND
FRMO CORP. Q1 REVENUE USD 802 THOUSAND
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
CV SCIENCES Q3 SALES USD 3.028 MILLION
CV SCIENCES Q3 SALES USD 3.028 MILLION
FX | Nov 12, 2026, 09:00 PM UTC
L
FRMO CORP. Q1 EPS USD -0.62
FRMO CORP. Q1 EPS USD -0.62
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
CV Sciences, Inc. Reports Third Quarter-End 2026 Financial Results
CV Sciences, Inc. Reports Third Quarter-End 2026 Financial Results SAN DIEGO, CA / ACCESS Newswire /
EQUITY | Nov 12, 2026, 09:00 PM UTC
L
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results
PALO ALTO, Calif., Nov. 12, 2026 // -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended September 30, 2026."We believe Kodiak stands apart in
EQUITY | Nov 12, 2026, 09:00 PM UTC
H
VINCI COMPASS REPORTS THIRD QUARTER 2026 EARNINGS RESULTS
RIO DE JANEIRO, Nov. 12, 2026 // -- Vinci Compass Investments Ltd. (NASDAQ:VINP) ("Vinci Compass," "the Company," "we," "us," or "our"), the controlling company of a leading alternative investments and global solutions p
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
AWH Reports Third Quarter 2026 Financial Results
Net revenue grew 4.2% year-over-year and 3.1% sequentially to $130.0 million in Q3 2026Generated Adjusted EBITDA1 of $31.1 million and Adjusted EBITDA Margin1 of 23.9%, as revenue growth drove operating leverageEnded Q3
EARNINGS | Nov 12, 2026, 09:00 PM UTC
M
Microsoft Validates Alternative Health Check, Restores Some Servers
Microsoft validated an alternative service health check method, allowing a subset of affected servers to return to service.
EQUITY | Nov 12, 2026, 09:00 PM UTC
L
Toronto Stock Exchange unofficially closes lower
EQUITY | Nov 12, 2026, 09:00 PM UTC
M
Toronto Stock Index Closes Down 274.53 Points
The index fell 274.53 points to 36,137.19 at the unofficial close.
EQUITY | Nov 12, 2026, 09:00 PM UTC
L
Rocket Pharmaceuticals, Inc. (RCKT) Reports Q3 2026 Results; Financial Figures Not Provided
Rocket Pharmaceuticals reported financial results for the quarter ended September 30, 2026, and provided business updates. The release provides no financial figures.Material DetailsContext by AI AnalystThis update sits a
EQUITY | Nov 12, 2026, 09:00 PM UTC
H
WORKHORSE GROUP POSTPONES THIRD QUARTER EARNINGS RELEASE AND CONFERENCE CALL
WORKHORSE GROUP POSTPONES THIRD QUARTER EARNINGS RELEASE AND CONFERENCE CALL
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
Mdxhealth Reports Third Quarter 2026 Financial Results
Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, Calif. — November 12, 2026 (GlobeN
EQUITY | Nov 12, 2026, 09:00 PM UTC
H
SpaceX Plans $74 Billion Spend on Data Centers in Texas and Arizona
SpaceX announced plans for data center projects in Texas and Arizona, expanding its AI infrastructure beyond the greater Memphis region.
EQUITY | Nov 12, 2026, 09:00 PM UTC
L
Wise Group plc H1 Results for Fiscal Year 2027
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- H1 FY27 H1 FY26 YoY Movement Active customers (millions)
EQUITY | Nov 12, 2026, 09:00 PM UTC
H
Birchcliff Energy Ltd. Announces Strong Q3 2026 Results and Preliminary 2027 Guidance
CALGARY, Alberta, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Birchcliff Energy Ltd.
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
KODIAK SCIENCES Q3 EPS USD -1.05
KODIAK SCIENCES Q3 EPS USD -1.05
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
ASCEND WELLNESS Q3 PRETAX PROFIT USD -17.418 MILLION
ASCEND WELLNESS Q3 PRETAX PROFIT USD -17.418 MILLION
EARNINGS | Nov 12, 2026, 09:00 PM UTC
H
VINCI COMPASS REPORTS THIRD QUARTER 2026 EARNINGS RESULTS
RIO DE JANEIRO, Nov. 12, 2026 /PRNewswire/ -- Vinci Compass Investments Ltd.
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
ASSEMBLY BIOSCIENCES Q3 BASIC EPS USD -0.93
ASSEMBLY BIOSCIENCES Q3 BASIC EPS USD -0.93
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
MDXHEALTH Q3 EPS USD -0.16
MDXHEALTH Q3 EPS USD -0.16
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
MDXHEALTH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
MDXHEALTH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:00 PM UTC
L
ASCEND WELLNESS Q3 NET INCOME USD -27.951 MILLION
ASCEND WELLNESS Q3 NET INCOME USD -27.951 MILLION
FX | Nov 12, 2026, 09:00 PM UTC
L
ASCEND WELLNESS Q3 EPS USD -0.14
ASCEND WELLNESS Q3 EPS USD -0.14
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
ASSEMBLY BIOSCIENCES Q3 NET INCOME USD -20.256 MILLION
ASSEMBLY BIOSCIENCES Q3 NET INCOME USD -20.256 MILLION
FX | Nov 12, 2026, 09:00 PM UTC
M
Dow Jones unofficially closes down 173.58 points, or 0.33%, at 52,312.91
EQUITY | Nov 12, 2026, 09:00 PM UTC
L
ASSEMBLY BIOSCIENCES Q3 EPS USD -0.93
ASSEMBLY BIOSCIENCES Q3 EPS USD -0.93
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
ROCKET PHARMACEUTICALS Q3 NET INCOME USD -49.2 MILLION
ROCKET PHARMACEUTICALS Q3 NET INCOME USD -49.2 MILLION
FX | Nov 12, 2026, 09:00 PM UTC
L
WISE GROUP PLC H1 RESULTS FOR FISCAL YEAR 2027
WISE GROUP PLC H1 RESULTS FOR FISCAL YEAR 2027
EQUITY | Nov 12, 2026, 09:00 PM UTC
L
AWH Reports Third Quarter 2026 Financial Results
Net revenue grew 4.2% year-over-year and 3.1% sequentially to $130.0 million in Q3 2026 Generated Ad
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
MDXHEALTH Q3 NET INCOME USD -12.259 MILLION
MDXHEALTH Q3 NET INCOME USD -12.259 MILLION
FX | Nov 12, 2026, 09:00 PM UTC
H
VINCI COMPASS REPORTS THIRD QUARTER 2026 EARNINGS RESULTS
VINCI COMPASS REPORTS THIRD QUARTER 2026 EARNINGS RESULTS
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
ASCEND WELLNESS Q3 REVENUE USD 130.019 MILLION
ASCEND WELLNESS Q3 REVENUE USD 130.019 MILLION
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
ROCKET PHARMACEUTICALS Q3 EPS USD -0.43
ROCKET PHARMACEUTICALS Q3 EPS USD -0.43
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
Mdxhealth Reports Third Quarter 2026 Financial Results
Mdxhealth Reports Third Quarter 2026 Financial Results Conference call with Q&A today at 4:30 PM EST
EQUITY | Nov 12, 2026, 09:00 PM UTC
H
Workhorse Group Postpones Third Quarter Earnings Release and Conference Call
DETROIT, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Workhorse Group Inc.
EARNINGS | Nov 12, 2026, 09:00 PM UTC
H
BIRCHCLIFF ENERGY LTD. ANNOUNCES STRONG Q3 2026 RESULTS AND PRELIMINARY 2027 GUIDANCE
BIRCHCLIFF ENERGY LTD. ANNOUNCES STRONG Q3 2026 RESULTS AND PRELIMINARY 2027 GUIDANCE
EARNINGS | Nov 12, 2026, 09:00 PM UTC
L
ASCEND WELLNESS Q3 OPERATING INCOME USD 4.5 MILLION
ASCEND WELLNESS Q3 OPERATING INCOME USD 4.5 MILLION
FX | Nov 12, 2026, 09:00 PM UTC
L
Rocket Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Recent Progress
FDA alignment establishes path to complete the pivotal Phase 2 trial of RP-A501 in Danon disease; do
REGULATION | Nov 12, 2026, 09:00 PM UTC